Angiogenic therapy for bronchopulmonary dysplasia: rationale and promise
- PMID: 16230495
- DOI: 10.1161/CIRCULATIONAHA.105.574061
Angiogenic therapy for bronchopulmonary dysplasia: rationale and promise
Comment on
- 
  
  Vascular endothelial growth factor gene therapy increases survival, promotes lung angiogenesis, and prevents alveolar damage in hyperoxia-induced lung injury: evidence that angiogenesis participates in alveolarization.Circulation. 2005 Oct 18;112(16):2477-86. doi: 10.1161/CIRCULATIONAHA.105.541524. Circulation. 2005. PMID: 16230500
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
- Full Text Sources
 
        